Eledon Pharmaceuticals Growth Metrics (2014-2017) | ELDN

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017
Growth Ratios
Assets Growth (1y) 233.71%-27.46%-36.91%-40.29%-46.39%-52.68%-98.24%-55.24%-42.71%-37.31%
Assets Growth (3y) -66.66%-40.08%
Assets (QoQ) 0.71%-10.30%-9.56%-11.21%-12.41%-15.10%-18.81%-21.63%-96.74%2,059.78%3.92%-14.25%
Capital Expenditures Growth (1y) 275.00%2,350.00%2,142.86%-62.22%-104.76%-98.73%-101.39%
Capital Expenditures Growth (3y) -40.10%
Capital Expenditures (QoQ) 200.00%-50.00%16.67%226.67%6.80%37.58%-92.13%-141.18%128.57%-250.00%
Cash & Equivalents Growth (1y) 231.48%248.57%179.36%-68.55%-77.18%-84.81%-79.43%-43.83%-95.35%70.59%85.76%2.87%
Cash & Equivalents Growth (3y) -67.23%-3.34%2.21%-43.36%
Cash & Equivalents (QoQ) -14.92%-21.71%398.65%-0.20%-10.54%-37.25%-43.86%-27.57%-40.46%-15.01%53.26%-94.00%2,084.42%-7.45%-15.13%
Cash from Investing Activities Growth (1y) -275.00%-404,816.67%-9,998.09%62.22%100.03%99.99%104.11%25,541.18%270,371.43%
Cash from Investing Activities Growth (3y) 73.80%612.97%1,367.06%
Cash from Investing Activities (QoQ) -200.00%50.00%-2,516.67%-53,888.89%34.74%98.01%94.62%141.18%-128.57%750.00%33,169.23%337.76%
Cash from Operations Growth (1y) 5.29%-132.50%-103.01%-129.61%-37.41%12.28%168.86%85.57%85.56%90.94%-205.98%-131.03%
Cash from Operations Growth (3y) 42.72%43.05%-14.00%8.52%
Cash from Operations (QoQ) 29.98%-13.51%17.65%-44.71%-71.89%0.89%6.86%13.40%-9.72%177.80%-119.52%13.32%31.20%-810.54%57.45%
EBIT Growth (1y) -12.83%-171.87%-52.63%-85.35%-76.84%13.68%-51.14%21.83%66.04%66.10%
EBIT Growth (3y) 12.17%7.34%
EBIT (QoQ) 11.84%-20.30%-9.16%2.54%-112.43%32.47%-32.57%7.01%-3.68%-18.25%31.43%59.60%-3.51%
EBT Growth (1y) -11.88%-173.57%-53.08%-85.49%-77.46%13.83%-51.01%21.79%66.08%66.16%
EBT Growth (3y) 12.35%7.26%
EBT (QoQ) 12.65%-20.71%-9.21%2.85%-113.60%32.45%-32.33%7.05%-3.71%-18.38%31.47%59.69%-3.45%
Enterprise Value Growth (1y) -231.48%-248.57%-179.36%68.55%77.18%84.81%79.43%43.83%95.29%-70.59%-85.87%-2.87%
Enterprise Value Growth (3y) 67.10%3.34%-2.23%43.36%
Enterprise Value (QoQ) 14.92%21.71%-398.65%0.20%10.54%37.25%43.86%27.57%40.46%15.01%-53.26%93.93%-2,057.38%7.40%15.18%
EPS (Basic) Growth (1y) 92.79%93.97%96.58%80.44%48.94%13.56%-43,332.75%-21,403.30%-1,892.64%-1,732.63%
EPS (Basic) Growth (3y) 9.83%1.53%
EPS (Basic) (QoQ) 26.48%-19.31%76.80%64.59%38.52%32.20%-32.50%7.55%-4.08%-33,964.90%34.40%91.43%4.27%
Free Cash Flow Growth (1y) 5.35%-132.85%-105.49%-132.77%-40.76%12.49%168.01%85.77%85.93%90.96%-205.88%-130.72%
Free Cash Flow Growth (3y) 42.77%43.10%-13.96%8.57%
Free Cash Flow (QoQ) 29.85%-13.35%17.62%-44.49%-72.59%-0.03%6.68%12.63%-7.30%177.74%-119.53%13.64%31.04%-810.54%57.45%
Net Cash Flow Growth (1y) -102.41%-134.10%-498.19%-130.74%-4,296.63%12.39%121.62%105.45%86.12%139.54%132.31%-342.00%
Net Cash Flow Growth (3y) -29.00%41.13%71.05%-26.84%
Net Cash Flow (QoQ) -154.85%-23.74%1,537.82%-100.25%-5,233.65%-216.19%26.12%64.71%-6.29%178.03%-81.38%-189.87%402.84%358.52%-119.39%
Net Income Growth (1y) -11.88%-173.57%-53.08%-85.49%-77.46%13.83%-51.01%21.79%66.08%66.16%
Net Income Growth (3y) 12.35%7.26%
Net Income (QoQ) 12.65%-20.71%-9.21%2.85%-113.60%32.45%-32.33%7.05%-3.71%-18.38%31.47%59.69%-3.45%
Net Income towards Common Stockholders Growth (1y) -12.06%-173.57%-53.08%-85.49%-77.46%13.83%-51.01%21.79%66.08%66.16%
Net Income towards Common Stockholders Growth (3y) 12.30%7.26%
Net Income towards Common Stockholders (QoQ) 12.51%-20.71%-9.21%2.85%-113.60%32.45%-32.33%7.05%-3.71%-18.38%31.47%59.69%-3.45%
Operating Income Growth (1y) -12.83%-171.87%-52.63%-85.35%-76.84%13.68%-51.14%21.83%66.04%66.10%
Operating Income Growth (3y) 12.17%7.34%
Operating Income (QoQ) 11.84%-20.30%-9.16%2.54%-112.43%32.47%-32.57%7.01%-3.68%-18.25%31.43%59.60%-3.51%
Profit After Tax Growth (1y) -12.36%-173.57%-53.08%-85.49%-77.46%13.83%-51.01%21.79%66.08%66.16%
Profit After Tax Growth (3y) 12.22%7.26%
Profit After Tax (QoQ) 12.27%-20.71%-9.21%2.85%-113.60%32.45%-32.33%7.05%-3.71%-18.38%31.47%59.69%-3.45%
Property, Plant & Equipment (Net) Growth (1y) 13.79%1,023.68%1,381.82%520.55%18.29%-72.60%-93.66%-82.34%-87.78%-59.83%
Property, Plant & Equipment (Net) Growth (3y) 2.25%7.34%
Property, Plant & Equipment (Net) (QoQ) -13.16%121.21%364.38%25.96%14.52%-7.36%-11.48%-70.82%-73.50%158.06%-38.75%-4.08%
Return on Assets Growth (1y) -40.00-38.00-54.00-59.00-138.00-156.0027.0078.00
Return on Assets (QoQ) -9.00-7.00-11.00-13.00-7.00-23.00-17.00-92.00-25.00161.0034.00
Return on Capital Employed Growth (1y) -45.00-44.00-68.00-76.00-185.00-199.00
Return on Capital Employed (QoQ) -10.00-7.00-13.00-15.00-9.00-31.00-20.00-125.00-22.00
Return on Equity Growth (1y) -45.00-44.00-66.00-79.00-208.00-218.0034.0096.00
Return on Equity (QoQ) -10.00-7.00-12.00-15.00-9.00-29.00-25.00-145.00-19.00222.0038.00
Share-based Compensation Growth (1y) 483.17%604.44%142.40%-31.81%45.50%61.20%63.70%-19.65%-96.62%-89.63%-86.90%-76.78%
Share-based Compensation Growth (3y) -34.03%5.61%-19.59%-49.70%
Share-based Compensation (QoQ) -10.89%177.78%371.60%-50.04%7.64%-4.42%32.67%6.59%19.25%-2.94%-34.88%-95.51%265.52%22.64%15.38%
Shareholder's Equity Growth (1y) 287.27%-29.24%-40.36%-43.44%-53.01%-57.92%-104.38%-54.55%-39.72%-31.85%
Shareholder's Equity Growth (3y) 63.43%-41.24%
Shareholder's Equity (QoQ) 1.86%-12.18%-8.96%-13.11%-14.15%-16.71%-24.36%-22.19%-108.93%964.69%0.32%-12.03%